Overview

Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects

Status:
COMPLETED
Trial end date:
2024-12-10
Target enrollment:
Participant gender:
Summary
To evaluate the absorption, metabolism and excretion in healthy Chinese male subjects after a single oral dose of \[14C\]HSK39297
Phase:
PHASE1
Details
Lead Sponsor:
Haisco Pharmaceutical Group Co., Ltd.